Seeing Is Believing
Currently, out of the existing stock ratings of Vamil Divan - 206 which are a Buy (59.88%), 125 which are a Hold (36.34%), 13 which are a Sell (3.78%)
Analyst Vamil Divan works at GUGGENHEIM and is covering the Healthcare sector with 701 price targets and ratings displayed on 33 stocks. Previously, Vamil Divan worked at MIZUHO, CREDIT SUISSE.
Vamil Divan's average stock forecast success ratio is 61.42% with an average time for price targets to be met of 243.22 days.
Most recent stock forecast was given on SAGE, Sage Therapeutics at 07-Sep-2023.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 8/9/2022. The price target of $276 was fulfilled within 3 days with a profit of $47.55 (20.81%) receiving and performance score of 69.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
170
$16.39 (10.67%)
163
1 months 24 days ago
33/34 (97.06%)
$24.97 (28.96%)
433
Buy
182
$28.39 (18.48%)
181
2 months 10 days ago
6/15 (40%)
$28.98 (32.96%)
467
Buy
155
5 months 16 days ago
1/1 (100%)
$21 (15.67%)
90
Buy
172
$18.39 (11.97%)
166
6 months 20 days ago
23/24 (95.83%)
$22.65 (31.91%)
519
Hold
127
6 months 30 days ago
1/1 (100%)
$21.13 (19.96%)
240